A Randomized, Double-Blind Study of the Effect of Olestra on Disease Activity in Patients With Quiescent Inflammatory Bowel Disease
Open Access
- 30 November 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 103 (5), 389-399
- https://doi.org/10.1016/s0002-9343(97)00164-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Chronic toxicity and carcinogenicity of olestra in Swiss CD-1 miceFood and Chemical Toxicology, 1994
- Experience with Eudragit-S-Coated Mesalamine (Asacol) in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1993
- Safety evaluation of olestra, a nonabsorbed, fatlike fat replacementCritical Reviews in Food Science and Nutrition, 1992
- Chronic toxicity and carcinogenicity studies of Olestra in Fischer 344 ratsFood and Chemical Toxicology, 1991
- A 20-month olestra feeding study in dogsFood and Chemical Toxicology, 1991
- Sorbitol malabsorption in normal volunteers and in patients with coeliac disease.Gut, 1988
- Abnormal Small Intestinal Permeability to Sugars in Patients with Crohn’s Disease of the Terminal Ileum and ColonDigestion, 1983
- Physical properties of pure sucrose octaestersChemistry and Physics of Lipids, 1978
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965
- Cortisone in Ulcerative ColitisBMJ, 1955